Real-World Evidence
Real-World Evidence (RWE) is transforming health
innovation. By monitoring the use and outcomes of
in-market medicines and devices, product
development is accelerating and healthcare
providers are improving care. Rymedi helps RWE
deliver greater value with enhanced data integrity
and more options for data sharing.
- Accelerate regulatory approvals
- Offer companion analytics for diagnostics and treatments
- Provide smart safety and efficacy assurance
- Expand data monetization options
Manufacturing for
Pharmaceuticals & Medical Devices
Life sciences manufacturing is getting smarter and
leaner. While traceability requirements increase
worldwide, manufacturers are leveraging improved
quality management for competitive advantage with
customers and regulators. Data also provides the
key to targeted process improvements and liability
reduction. Keep all your existing systems and use
Rymedi to enrich your data and improve overall
value.
- Assure customers and regulators full cGXP traceability
- Reduce liabilities with compliance automation and targeted remediation
- Enhance performance with data-driven costing, training and IRs
- Maintain versioning to reduce the cost of your IQ/OQ/PQ processes
Supply Chains
Data is driving supply chain efficiencies and risk
reduction. New supply traceability regulations are
guarding against counterfeits and securing
medicine and device quality across distribution
networks. Trusted product traceability also
enables business model innovations for expanded
market access. Let Rymedi turn your supply
intelligence into smart value chains.
- Provide higher quality assurance
- Streamline logistics management
- Link compliance data with other data for higher value
- Expand differential pricing and contracting options across varied markets
Collaborative Research
With collaboration accelerating breakthroughs,
Collaborative Research Notebook (CRN) is Rymedi’s
solution to research management. The
blockchain-enabled dashboard, IoT integration, and
collaboration tools link to immutable records of
activities relevant to publication credits and
intellectual property claims. Data access on a
permissioned need-to-know basis provides targeted
data sharing, while holding back elements crucial
for trade secrecy. Rymedi allows researchers to
focus on their objectives and fully harness
collaborative science, rather than worry about
trademarks or security.
- Eliminate intellectual property disputes
- Automate regulatory compliance
- Enhance verification of cleaned and calibrated equipment
- Enable secure data sharing between parties
Clinical Trials Management
Clinical trials are being revolutionized by
digital technologies. Digital data from wearables,
mHealth apps, devices and EMRs requires
regulatory-compliant data plumbing for full
reliance by regulators. Meanwhile, labor-intensive
transcription, monitoring and auditing processes
account for much of the cost of later-stage
trials. Rymedi data infrastructure is paving the
highway towards faster, leaner, smarter trial
design and management.
- Automate data capture, monitoring and auditing
- Harness real-time data visibility and analytics across sites and partners
- Accelerate validated investigator payments
- Leverage permissioned, targeted data sharing for research alliances
Hemp CBD
With the signing into law of the latest U.S. Farm
Bill, CBD products are coming under federal
regulation. Greater regulatory clarity is already
driving an explosion of interstate and global CBD
market growth. Rymedi is providing
pharmaceutical-grade compliance and quality
assurance for a trusted, thriving global CBD
market.
- Accelerate market access and growth
- Validate hemp producers through pharma regulatory compliance
- Track and trace from seed to finished products
- Provide quality risk management throughout product life-cycles
